At ID + BIOTEC we carry out technological research and development activities of interest to hospitals and the pharmaceutical industry, which will later serve as a technological platform for the creation of new business initiatives in the Biomedicine sector.

 

We have a research center in Translational Medicine in which clinical and analytical research are articulated and whose objective is to transfer our advances in knowledge about the new molecular mechanisms involved in physiological and pathophysiological processes to clinical medicine.

 

In our laboratories, we enrich clinical research with experimental disease models, which reproduce pathogenic mechanisms and molecular pathophysiological parameters, and which serve to evaluate new therapeutic lines for pharmaceutical innovation and for the discovery of new molecular biomarkers.

 

In the genomics area, we carry out the extraction, purification and direct sequencing of the complete genome DNA, genotyping and gene expression.

 

In conjunction with the study of Pharmacogenomics, we develop the bases of personalized medicine, based on the genetic characteristics of each individual through the study of molecular and cellular alterations, in the development of diseases and their treatment.